Hansa Biopharma appoints Fredrik Röök as VP business development
PUBT · 3d ago
Share
Listen to the news
- Hansa Biopharma named Fredrik Röök vice president of business development, effective Aug. 17, reporting to CEO Renée Aguiar-Lucander.
- Röök joins from AstraZeneca, where he was senior director of global business development focused on partnering, licensing, M&A, and strategic deals.
- Appointment strengthens dealmaking capacity as the group advances its pipeline and evaluates new strategic opportunities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hansa Biopharma AB published the original content used to generate this news brief on June 10, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending